Ticker

6/recent/ticker-posts

Statement on the seventh meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic

 


The seventh meeting of the Emergency Committee on Corona Viral Disease (COVID-19) under the International Health Regulations (2005) (IHR) by the Director General of WHO was held on Thursday, April 15, 2021 at 12:00 p.m. 16:30 to Geneva (CEST).


Continuation of the meeting

Emergency team members and advisors were invited via video conference.


The Director-General welcomed the team and expressed concern over the continued increase in cases and deaths and the need to promote vaccination efforts around the world. He thanked the team for their continued support and advice.


The Office of Legal Advisors (LEDs) and Compliance, Risk Management and Ethics (CRE) representatives explained their roles and responsibilities to the members. The CRO Protocol Officer provided an overview of the WHO Interest Procedure Notice to members and advisors. Members and consultants become aware of the personal responsibility to the WHO to state that, in a timely manner, any perceived interest, personal, professional, financial, intellectual or professional, may result in a perceived or direct conflict of interest . The meeting further reminded that it was their duty to maintain the credibility of the discussions and the work of the committee. Each current member was surveyed and no interest was identified. Two members called for a global study of the origin of SARS-CoV-2 and an advisory member of the joint international team agreed not to contribute to the panel's recommendations regarding its origin and occurrence investigation. Virus.


The Secretary-General gave Prof. Presented the meeting to Didier Housein. Professor House expressed concern about current COVID-19 transition trends and reviewed the objectives and agenda of the meeting.


The Secretary presented the following topics and answered the committee's questions.


There was progress in the WHO reaching the Secretariat on 15 January 2021;

International dissemination of activities of WHO, which is to ensure global, regional epidemiological trends, process monitoring, monitoring and analysis for SARS-COV-2 variants, to understand the origin of SARS-COV-2 Task update and integrated response to COVID-19;

Global rolling and COVID-19 vaccine involvement, the effect of vaccines on symptomatic infection and spread, and vaccine efficacy against various concerns (VOCs);

WHO analysis of the effect of SARS-CoV-2 anxiety variance on public health interventions; In

Overview of WHO activities related to international transport related health activities.

Thanks to the Committee Secretariat for the quality of presentations presented, the COVID-19 pandemic is still an extraordinary phenomenon that affects the health of people around the world and is in danger of spreading. Interference in international and international transport. , And requires a unified international response. Consequently, the committee acknowledged that COVID-19 Pandemic International Concern (PHEIC) is a public health emergency and provided advice to the Director General.


The panel stated that previous recommendations would be relevant to current response efforts worldwide. The committee requests the IHR Secretariat to review previous suggestions and interim recommendations and bring to the committee a plan for new publication, completeness, or consultation and revision of interim recommendations.


The committee acknowledges the progress of WHO parties and states in implementing the previous recommendations and the interim recommendations from the 6th meeting of the Emergency Committee. The group welcomed the mission team and report on the WHO's call for a global study of SARS-COV-2 and encouraged the implementation of the recommendations made in the mission report. The group was concerned that the world would not be epidemic-free if all countries did not have access to products suitable for diagnosis, treatment, and vaccines, regardless of their potency and efficiency. And financial resources to immunize its people quickly and efficiently. Inequalities in all countries slow down the return to normal social and economic life. The committee made the following suggestions to the Director General.


The Director-General determined that the COVID-19 pandemic still continued to produce PHEIC. He accepted the advice of the WHO committee and submitted the advice of the Committee of States Parties as an interim recommendation under the IHR.

At the discretion of the Director-General, the Emergency Committee may rework within three months or even earlier. The Director General thanked the team for their work.


Consultation with WHO Secretariat

COVIT-19 commentary


Promote global cohesion and equal access to the vaccine by encouraging state parties and manufacturers to support the Kovacs facility, including the distribution of vaccine supplements and technology transfer for local production of COVID-19 vaccines and low- and medium- Including size - product included. Products. Countries with average potential income.

State parties in strengthening their regulatory agencies to accelerate the evaluation of COVID-19 vaccine candidates, encourage regulatory agencies to use specific methods, and facilitate delivery of vaccines with specific quality, effectiveness, and safety. To support.

To mobilize technical support and financial support to the States Parties with adequate capacity and financial resources for the introduction and release of the vaccine.